TG Therapeutics EPS - Earnings per Share 2010-2024 | TGTX

TG Therapeutics earnings per share (EPS) for the twelve months ending September 30, 2024 was $-0.03, a 89.29% decline year-over-year.

  • TG Therapeutics EPS for the quarter ending September 30, 2024 was $0.02, a 97.26% decline year-over-year.
  • TG Therapeutics 2023 annual EPS was $0.09, a 106.16% decline from 2022.
  • TG Therapeutics 2022 annual EPS was $-1.46, a 44.49% decline from 2021.
  • TG Therapeutics 2021 annual EPS was $-2.63, a 8.68% increase from 2020.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.

TG Therapeutics EPS - Earnings per Share 2010-2024 | TGTX

  • TG Therapeutics EPS for the quarter ending September 30, 2024 was $0.02, a 97.26% decline year-over-year.
  • TG Therapeutics 2023 annual EPS was $0.09, a 106.16% decline from 2022.
  • TG Therapeutics 2022 annual EPS was $-1.46, a 44.49% decline from 2021.
  • TG Therapeutics 2021 annual EPS was $-2.63, a 8.68% increase from 2020.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.